Personomics: The Missing Link from Precision Medicine to Personalized Medicine

Personomics: The Missing Link from Precision Medicine to Personalized Medicine

Last Updated on October 22, 2017 by Ziegelstein RC

October 21, 2017 – Just seen on PubMed:

Ziegelstein RC

 

J Pers Med 2017 Oct;7(4)

PMID: 29035320

Abstract

It is all about people who one day may turn into individual patients.

Clinical practice guidelines have been developed for many common conditions based on data from randomized controlled trials. When medicine is informed solely by clinical practice guidelines, however, the patient is not treated as an individual, but rather a member of a group. Precision medicine, as defined herein, characterizes unique biological characteristics of the individual or of specimens obtained from an individual to tailor diagnostics and therapeutics to a specific patient. These unique biological characteristics are defined by the tools of precision medicine: genomics, proteomics, metabolomics, epigenomics, pharmacogenomics, and other “-omics.” Personalized medicine, as defined herein, uses additional information about the individual derived from knowing the patient as a person. These unique personal characteristics are defined by tools known as personomics which takes into account an individual’s personality, preferences, values, goals, health beliefs, social support network, financial resources, and unique life circumstances that affect how and when a given health condition will manifest in that person and how that condition will respond to treatment. In this paradigm, precision medicine may be considered a necessary step in the evolution of medical care to personalized medicine, with personomics as the missing link.

See the full open access article here. There is an additional article on the topic here. We encourage our readers to dive into these exciting readings on personal aspects of the precision “-omics” age of things.

_______________

Ph.D.; Professor in Pharmacology and Toxicology. Senior expert in theragenomic and personalized medicine and individualized drug safety. Senior expert in pharmaco- and toxicogenetics. Senior expert in human safety of drugs, chemicals, environmental pollutants, and dietary ingredients.

Your opinion

Comment

No comments yet